Clinica Universitaria de Navarra

Madrid 28027

0 studies enrolling now · 3 studies all time

What they study most

Diabetic Macular Edema, Multiple Myeloma, Wet Macular Degeneration

Studies at this site

• MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb — Running, not enrolling
• A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA) — Completed